Article
Factor V Leiden and FII 20210 testing in thromboembolic disorders.
Clinical chemistry and laboratory medicine - 1 Dec 2010
Pajič Tadej
Abstract excerpt
Factor V Leiden and prothrombin (F2) c.20210G>A mutation detection are very important in order to define the increased relative risk for venous thromboembolism in selected patients. Use of DNA-based methods to detect both mutations has become widely available in clinical diagnostic laboratories, including fluorescence-based quantitative real-time PCR (qPCR). The latter is a rapid, simple, robust and reliable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
